Past, Present, and Future of The Journal of Clinical Immunology, the International Journal of Inborn Errors of Immunity
- PDF / 240,899 Bytes
- 3 Pages / 595.276 x 790.866 pts Page_size
- 20 Downloads / 189 Views
EDITORIAL
Past, Present, and Future of The Journal of Clinical Immunology, the International Journal of Inborn Errors of Immunity Vincent R. Bonagura 1,2,3,4 & Jean-Laurent Casanova 5,6,7,8,9
# Springer Science+Business Media, LLC, part of Springer Nature 2020
* Vincent R. Bonagura [email protected]
Journal of Clinical Immunology 2013-2019 Stascs 8
Laboratory of Host Defense, The Feinstein Institute for Medical Research , Manhasset, NY, USA
2
Division of Allergy and Immunology, Departments of Pediatrics and Internal Medicine, Great Neck, NY, USA
3
Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Hempstead, NY, USA
200
5 4
150
3
100
2
Number of Downloads
250
6
50
1 0
0 2013
2014
2015
2016
2017
2018
2019
Years Impact factor
Number of Downloads
In 2013, the IF of the JoCI was 2.83 which rose to 3.89 in 2015, and over the past 7 years, there has been a steady
4
Steven and Alexandra Cohen Children’s Medical Center of New York, Great Neck, NY, USA
5
St Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
6
Howard Hughes Medical Institute, New York, NY, USA
7
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France
8
University of Paris, Imagine Institute, Paris, France
9
Pediatric Hematology and Immunology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France
Jean-Laurent Casanova [email protected] 1
300
7
Impact factor
Dear Readers and Friends, We write to share great news about the extraordinary rise of our Journal’s impact factor (IF) that has risen from 4.13 in 2018 to 6.78 in 2019 [1]. We began our journey in 2013 [2], and refocused the JoCI as the International Journal for Inborn Errors of Immunity (IEI) [3]. Together, we gradually appointed a new board of elite and international Associate Editors, and expanded the full Editorial Board to reflect the diversity and international scope of the clinical and research community that cares for and studies children and adults with IEI. During the first 5 years of our tenure in leading the JoCI, sponsored by the CIS, we have added six supporting IEI Societies to the Journal, and we are in the process of adding an additional international IEI society in 2019.
J Clin Immunol
increase in the IF for the Journal (see accompanying figure). This year, there was a notable rise in the IF above 5 for the first time in the history of the journal. Collectively, we achieved this exceptional rise in our IF without distorting the content of the JoCI in favor of trendy or fashionable topics. We have only been guided by three principles: first, we have focused the journal on IEI; second, we have strived to improve the quality of the published papers; and third, we have published the very best work submitted to us as CME Reviews [4–7], How I Manage [8–10], and Original Articles [11–15], while having the community at large share their clinical experience
Data Loading...
